Health Care & Life Sciences » Biotechnology | Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 91.5 M
Public Float
 84.97 M
Inovio Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $1
Market Cap
 $296.06 M
Shares Outstanding
 98.03 M
Public Float
 89.22 M

Profile

Address
660 West Germantown Pike
Plymouth Meeting Pennsylvania 19462
United States
Employees -
Website http://www.inovio.com
Updated 07/08/2019
Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Financials

View All
Created with Highcharts 5.0.14Inovio Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.66 02866 02836 12136 12129 18729 18773 74073 74088 20588 20596 96796 967201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Inovio Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.13 46713 46710 45610 45640 57240 57235 36835 36842 22042 22030 48130 481201320142015201620172018010k20k30k40k50k

Avtar S. Dhillon
Non-Executive Chairman
J. Joseph Kim
President, Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.